期刊文献+

EGFR和C-erbB2在非小细胞肺癌中的表达及研究前景 被引量:3

暂未订购
导出
摘要 肺癌的发生和发展是一个多因素多阶段的过程 ,表现为癌基因、抑癌基因、肿瘤转移相关基因的点突变、扩增、异位和缺失 ,以及某些抗原分子的异常表达。表皮生长因子受体 (EGFR)和C erbB 2癌基因在非小细胞肺癌中过表达并与肿瘤的生长转移及患者的预后密切相关 ,但在小细胞肺癌中未发现过表达。本文综述了EGFR和C erbB2的结构、功能、同源性及在正常组织中的分布 ,重点讨论了EGFR和C erbB2在非小细胞肺癌 (NSCLC)发生发展中的作用及在NSCLC的诊断、治疗。
出处 《陕西肿瘤医学》 CAS 2001年第4期292-293,共2页 ShanXi Oncology Medicine
  • 相关文献

参考文献19

  • 1David B Weiner, Joanne Nordberg, et al. Expression of the neu Gene-encoded protein(p185neu) in human non-small cell carcinomas of the lung[J]. Cancer Res, 1990,50(15) :421~425.
  • 2Jeffrey A.K, David A.S, et al .p185neu Expression in Human Lung Adenocarcinomas Predicts Shortened Suruval [J]. Cancer Res, 1990,50:5184~5191.
  • 3Kwa HB,Verheijen MG, et al. Prognostic factors in resected nonsmall eell lung cancer: an immunohistochemical study of 39 cases[J]. Lung Cancer, 1996,16(1):35~45.
  • 4John D, Mina. M.D., The Molecular Biology of Lung Cancer Pathogenesis[J]. Chest, 1993,103: 449S~456S.
  • 5Yarden Y,Ullrich A. Growth factor receptor tyrosine kinases[J].Annu Rev Biochem, 1998,57: 443~478.
  • 6Susan A, Chrysogelos, Ronit Yarden, et al .Mechanisms of EGF receptor regulation in breast cancer cells [J].Breast Cancer Research and treatment, 1994,31:227~236.
  • 7Masahiro Tateishi, Teruyoshi Ishida, et al. Immunohistochemical Evidence of Autocrine Growth Factors in Adenocarcinoma of the Human Lung[J ]. Cancer Res, 1990,50: 7077~7080.
  • 8Schecter A.L.,Hung. M.C,et al.The neu gene:an erbB homologous gene distinct from and unlinked to the gene encoding the EGF receptor[J]. Science, 1985,229:976~978.
  • 9Johnson G,Kannan B,et al .Amphiregulin induces tyrosine kinases phosphorylation of the epidermal growth factor receptor and p185neu[J]. J Biol Chem, 1993,268: 2924~2931.
  • 10Slamon D. J, Stuart S. G, et al. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer [J].Science,1989,244: 707~712.

二级参考文献3

共引文献8

同被引文献28

  • 1Strasser A,Puthalakath H,Bouillet P,et al.The role of Bim,aproapoptotic BH3-only member of the Bcl-2 familyin cell-death control[J].Ann NY Acad Sci,2000,917(1):541-558.
  • 2Sunters A,Madureir P A,Pomeranz K M,et al.Paclita-xel-induced nuclear translocation of FOXO3a in breastcancer cells is mediated by c-Jun NH2-terminal kinase andAkt[J].Cancer Res,2006,66(1):212-220.
  • 3Desbien A L,Kappler J W,Marrack P.The Epstein-Barrvirus Bcl-2 homolog,BHRF1,blocks apoptosis by bind-ing to a limited amount of Bim[J].Proc Natl Acad Sci US A,2009,106(14):5663-5668.
  • 4Costa D B,Halmos B,Kumar A,et al.BIM mediatesEGFR tyrosine kinase inhibitor-induced apoptosis in lungcancers w ith oncogenic EGFR mutations[J].PLoS Med,2007,4(10):1669-1680.
  • 5Pao W,Miller V A,Politi K A,et al.Acquired resist-ance of lung adenocarcinomas to gefitinib or erlotinib isassociated w ith a second mutation in the EGFR kinase do-main[J].PLoS Med,2005,2(3):e73.
  • 6Gadgeel S M,Ali S,Philip P A,et al.Genistein en-hances the effect of epidermal grow th factor receptor tyro-sine kinase inhibitors and inhibits nuclear factor kappa Bin nonsmall cell lung cancer cell lines[J].Cancer,2009,115(10):2165-2176.
  • 7Jackman D M,Miller V A,Cioffredi L A,et al.Impactof epidermal grow th factor receptor and KRAS mutationson clinical outcomes in previously untreated non-small celllung cancer patients:results of an online tumor registry ofclinical trials[J].Clin Cancer Res,2009,15(16):5267-5273.
  • 8Kobayashi S,Ji H,Yuza Y,et al.An alternative inhibi-tor overcomes resistance caused by a mutation of the epi-dermal grow th factor receptor[J].Cancer Res,2005,65(16):7096-7101.
  • 9Suda K,Onozato R,Yatabe Y,et al.EGFR T790Mmutation:a double role in lung cancer cell survival?[J].J Thorac Oncol,2009,4(1):1-4.
  • 10Wu S G,Chang Y L,Hsu Y C,et al.Good response togefitinib in lung adenocarcinoma of complex epidermalgrow th factor receptor(EGFR)mutations w ith the clas-sical mutation pattern[J].Oncologist,2008,13(12):1276-1284.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部